Prosperity Financial Group, Inc. Sellas Life Sciences Group, Inc. Transaction History
Prosperity Financial Group, Inc.
- $201 Billion
- Q4 2024
A detailed history of Prosperity Financial Group, Inc. transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Prosperity Financial Group, Inc. holds 11,500 shares of SLS stock, worth $13,224. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,500Holding current value
$13,224% of portfolio
0.01%Shares
4 transactions
Others Institutions Holding SLS
# of Institutions
37Shares Held
6.49MCall Options Held
1.8MPut Options Held
49.7K-
Vanguard Group Inc Valley Forge, PA2.29MShares$2.64 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX1.19MShares$1.37 Million0.16% of portfolio
-
Geode Capital Management, LLC Boston, MA734KShares$843,5770.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il485KShares$558,1140.0% of portfolio
-
Black Rock Inc. New York, NY430KShares$494,9230.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $23.6M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...